Source: Trump and COVID-19 Oct 05, 2020 1 year ago
Trump-COVID-19: The president’s personal physician has now acknowledged delivering an overly rosy picture of his illness a day earlier to please his notoriously sensitive patient but declined to comment on the actual status of his patient, adding more confusion to the developing situation.
Health experts after analyzing details of the briefing on Sunday coupled with previous press briefin...
COVID-19 News: A new study led by British researchers from University Of Surrey along with scientist from University of Manchester, Aston University, University of Leicester and the Frimley Health NHS Trust Hospital have found that most individuals infected with the SARS-CoV-2 coronavirus that causes the COVID-19 disease are likely to develop dyslipidemia and changes in their sebum lipodomes that ...
SARS-CoV-2 News: Researchers from the University of Barcelona-Spain; Xiamen University0China; and IHU-Méditerranée Infection and CNRS-France provide more new evidence to dispute the hypothesis that pangolins were the intermediate animals in SARS-CoV-2 transmission to humans.
Their research findings are published in the peer-reviewed journal: Infection, Genetics and Evolution...
COVID-19 Test: A large multidisciplinary group of researchers from University of California-San Francisco, J. David Gladstone Institutes-San Francisco, University of California-Berkeley, Monash University-Australia and Chan Zuckerberg Biohub-San Francisco have developed an amplification-free CRISPR-based mobile phone assay for direct detection of the severe acute respiratory syndrome coronav...
COVID-19 Latest: Researchers from Korea Advanced Institute of Science and Technology (KAIST), by detail analysis of the airway cell transcriptome have identified an activated immune axis that could pinpoint the COVID-19 patients who will most benefit from targeted therapies.
The study team re-analyzed published scRNA-seq data of COVID-19 patient bronchoalveolar lavage fluid...
Source: Trump-COVID-19 Updates Oct 05, 2020 1 year ago
Trump-COVID-19 Updates: Trump’s doctors said on early Sunday that he "continued to improve" as he is being treated for COVID-19 at a military hospital near Washington, adding that he could be discharged as early as Monday.
Dr Brian Garibaldi
During an early Sunday briefing outside Walter Reed medical center, the doctors said that Trump's oxygen levels had briefly dropped onl...
Vaccine News: Researchers from Harvard’s Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences (SEAS) along with support from Perelman School of Medicine, University of Pennsylvania, have developed a platform technology that uses red blood cells to deliver antigens to antigen-presenting cells (APCs) in the spleen, generating ...
COVID-19-Eyes: Doctors from India have reported the first documented case vasculitic retinal vein occlusion due to COVID-19.
The documented report was submitted by Dr Jay Umed Sheth and colleagues from the Surya Eye Institute and Research Centre in Mumbai.
The detailed case report has been published in the Indian Journal of Ophthalmology. https://www.ijo.in/article.asp?issn=0301-47...
Source: COVID-19 And Cancer Oct 03, 2020 1 year ago
COVID-19-Cancer: A new study by researchers from The University of Arkansas for Medical Sciences (UAMS) have shown that SARS-CoV-2 encoded proteins along with certain drugs currently used in COVID-19 treatment protocols are able to induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of major human oncogenic viruses through manipulation of intracellular signaling ...
Source: TRUMP-COVID-19 Cluster Oct 03, 2020 1 year ago
TRUMP-COVID-19 Cluster: More reports are emerging that not only has Trumps Election Campaign Manager Bill Stepien tested positive but many others close to him or interacted with him the past week have also tested positive for the SARS-CoV-2 coronavirus.
It must be noted that American President seldom wears any protective mask and that he was never seen in it especially the las...
COVID-19 Drugs: An urgent immediate safety review of the drug Remdesivir has been called by the European Medicines Agency after numerous COVID-19 patients taking the drug have developed serious kidney problems.
The EU regulator issued a statement a few hours ago saying that it seemed that remdesivir was causing the "acute kidney injury," and that the issue "warrants further...
COVID-19 Testing: Researchers from University of Vermont, working in collaboration with a group from the University of Washington, have developed a platform of testing for the COVID-19 disease that does not make use of key chemicals, or reagents but still delivers an accurate result, paving the way for inexpensive, widely available testing in both developing countries and industrialized nations li...
Trump-COVID-19: President Donald Trump is receiving an experimental treatment of synthetic antibodies for COVID-19, his doctor said Friday, and is "fatigued but in good spirits."
President Leaving For Walter Reed Military Hospital
President Trump received a single dose of Regeneron's antibody cocktail, according to a letter issued by White House physician Dr Sean Conley.
Th...
Source: COVID-19 Thailand News Oct 02, 2020 1 year ago
COVID-19 Thailand News: Former Thai Prime Minister Thaksin Shinawatra who is in self-exile and certain members of his family were sent to hospital for contracting the SARS-CoV-2 coronavirus according to emerging media reports.
Thaksin currently lives in a massive mansion in the city of Dubai in the United Arab Emirates.
It was reported that he was feeling unwell since yesterday and...
Source: COVID-19 BREAKING UPDATES Oct 02, 2020 1 year ago
COVID-19 BREAKING UPDATES! Challenging times are back again and this time it is going to be even more worse and it would be truly interesting seeing those who were in denial or those who were saying that COVID-19 is non-existence or those who were accusing this website of fear mongering etc.
Since January till now, all our predictions, hypothesis etc have never been wrong and in fact we h...
COVID-19 Herbs: Rooibos a popular herbal tea that is obtained from the leaves of a South African shrub Aspalathus linearis, is now being the center of focus in a series of international studies to assess its possible use as an adjuvant to treat COVID-19 and also as a ingredient in a series of herbal products to treat COVID-19 and also as a prophylaxis against the SARS-CoV-2 coronavirus.
D...
U.S.News: President Trump and First Lady Melania Trump have contracted the COVID-19 disease according to an announcement by Trump himself and also by his wife and the first announcement was not by any White House official or Health Professional!
President Donald Trump announced early Friday that he and his wife both tested positive for the SARS-CoV-2 coronavirus, an extraordinary de...
Virus News: A new study by researchers from the Medical University of Vienna highlights the risk of hospitalized COVID-19 patients developing venous thromboembolism or VTE.
The study findings were published in the journal: Research and Practice In Thrombosis and Haemostasis.
https://onlinelibrary.wiley.com/doi/10.1002/rth2.12439
The study which for the first time, provide an in-dep...
Medical Law: According to a new research paper in the journal Science co-written by a University of Illinois, Urbana-Champaign legal expert who studies the policy implications of advanced biotechnologies. well-intentioned “citizen scientists” developing homemade COVID-19 vaccines may believe they are inoculating themselves against the ongoing pandemic, but the pract...
Source: Parkinson's Disease-COVID-19 Oct 02, 2020 1 year ago
Parkinson's Disease-COVID-19: Researchers from University of Iowa in a new study involving approximately 80,000 patients shows that individuals with Parkinson's disease (PD) have a 30% higher risk of dying from COVID-19 than individuals without the neurodegenerative condition.
The study findings were published in the journal: Movement Disorders, the official journal of the Interna...
Immune System: Emerging research by scientist from University of Rochester-New York show how different cells in the immune system work together, communicate, and in the case of cells called neutrophils bring about their own death to help fight off infections.
The study findings are published in the journal: Nature. Immunology https://www.nature.com/articles/s41590-020-0746-x
&n...
COVID-19 Research: Scientist from the Massachusetts Institute of Technology (MIT) in a new research study have discovered high-affinity peptide binders for the SARS-CoV-2 spike glycoprotein that can inhibit infection. The study also opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.
The study findings ...
Canada News: It was announced on Latest on Wednesday that Canada has extended a ban on non-essential international entries until the end of October as the country was gripped by a surge in COVID-19 cases.
The further extension comes amid a second wave of infections caused in part by the return to school or work of millions of Canadians after summer breaks.
Public Sa...
COVID-19 Latest: Researchers from the University of Pittsburgh School of Medicine-Pittsburgh and Icahn School of Medicine at Mount Sinai-New York, in a new study involving the autopsy and histological studies of dead COVID-19 patients who had severe conditions, have discovered the extensive lung tissue and cell damage that infection with the SARS-CoV-2 coronavirus causes.
The study findin...
Source: SARS-CoV-2 Strains Oct 01, 2020 1 year ago
SARS-CoV-2 Strains: Researchers from Philippines and Thailand in a new study have identified a total of 23 different distinct strains circulating in the Philippines including the potent and infectious D614G Strains.
The study results are published on a preprint server but are currently being peer-reviewed for publication into a journal. https://www.medrxiv.org/content/10.1101/2020.09.29.2...
Source: Pregnancy And COVID-19 Oct 01, 2020 1 year ago
Pregnancy And COVID-19: Canadian researchers from the University of Toronto, Sinai Health Systems-Toronto, Lunenfeld-Tanenbaum Research Institute-Toronto along with support from the University of Minas Gerais-Brazil have in a new study found that maternal immune cells actually help to spread the SARS-CoV-2 coronavirus to the placenta.
In the study, the researchers provided evidence that u...
Vaccines-COVID-19: The NIAID And Moderna Inc Phase 1 clinical trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.
The trial results were published in the New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2028436
The new experimental v...
Source: AI-Artificial-Intelligence-COVID-19 Oct 01, 2020 1 year ago
AI-Artificial Intelligence-COVID-19: Researchers from the U.S. NIH, University of Central Florida, State University of New York, NVIDIA Corporation and University of Milano have developed an algorithm can accurately identify COVID-19 cases, as well as distinguish them from influenza.
The study shows that artificial intelligence can be nearly as accurate if not even better than a phy...
Drugs-COVID-19: Anti-tumour necrosis factor (anti-TNF) drugs or TNF inhibitors are now being explored by numerous researchers to treat COVID-19 after recent studies of patients with COVID-19 have shown that patients already taking anti-TNF drugs for inflammatory bowel disease and inflammatory arthritis are less likely to be admitted to hospital. The same was not observed for patients taking other ...
Delirium-COVID-19: A new study by researchers from King's College London involving detailed meta-analysis of data and information procured from the COVID Symptom Study app and patients admitted to St Thomas' Hospital in London, has shown that delirium, a state of acute confusion associated with a higher risk of serious illness and death is a key symptom of COVID-19 in frail, older individu...
Strokes-COVID-19: According to a new study led by Canadian researchers from Western University -Ontario, strokes may be the first presenting symptom of COVID-19 in younger patients who are typically asymptomatic.
The new study findings were published in the peer reviewed journal: Neurology, the medical journal of the American Academy of Neurology. https://n.neurology.org/content/early/202...
U.S. News: Most Americans were oblivious to our headlines and breaking news today on a new research that confirms that the SARS-CoV-2 coronavirus actually attacks the CD4 T Cells, literally elevating the COVID-19 disease to a ‘potent airborne HIV-like disease.’ https://www.thailandmedical.news/news/breaking-news-covid-19-study-reveals-that-sars-cov-2-uses-cd4-cells-to-infect-t-helper-l...
Source: COVID-19 Intranasal Drugs Sep 30, 2020 1 year ago
COVID-19 Intranasal Drugs: Researchers from the National Infection Service-UK, Ena Respiratory, Melbourne-Australia, The University of Melbourne-Australia, University of Newcastle-Australia and Oxford University-UK are exploring the usage of TLR2/6 Agonist INNA-051 as an intranasal prophylaxis against COVID-19.
To date their vivo studies involving animal models showed that the TLR2 agonis...
Source: Obstructive Sleep Apnea Sep 30, 2020 1 year ago
Obstructive Sleep Apnea (OSA) increases the risk of severe COVID-19 according to a new research led by University of Helsinki-Finland and involving Broad Institute of MIT, Harvard, Stanford University and Massachusetts General Hospital.
Information regarding obstructive sleep apnea (OSA) diagnosis and COVID-19 infection was extracted from the FinnGen study (N=260,405) with a total of 305 ...
Breaking News: A multi-disciplinary team of researchers from University of Campinas (UNICAMP)- Brazil have in a new study discovered and proved that the SARS-CoV-2 infects human CD4+ T helper cells, but not CD8+ T cells, and is present in blood and bronchoalveolar lavage T helper cells of severe COVID-19 patients.
The study findings are published on a preprint server but are already being...
Source: COVID-19 Latest Headlines Sep 30, 2020 1 year ago
COVID-19 Latest Headlines: Researchers from Brigham and Women's Hospital and Harvard Medical School have utilized VirScan, a technology that can determine which of more than 1,000 different viruses have infected an individual including SARS-CoV-2 to discover more than 800 epitopes on the SARS-CoV-2 genome. The epitope is the part of an antigen molecule to which an antibody attaches itself to.
...
COVID-19 Research: A study led by researchers from the University of Cincinnati along with scientists from University of Duisburg-Germany, the German Primate Center and Saarland University-Germany have discovered that sphingosine, a naturally occurring lipid in the human body could be used as a potential treatment for COVID-19 as prevents binding of SARS-CoV-2 spike to its cellular receptor ...
Source: Nutrition And Diets Sep 29, 2020 1 year ago
Nutrition And Diets: Researchers from University of Gothenburg-Sweden, Lund University-Sweden and the University of South Australia in a preclinical study found that dietary oat bran can offset chronic gastrointestinal damage caused by radiotherapy, contradicting long-held clinical recommendations.
The goal of this study was to evaluate the influence of dietary fiber on radiation-ind...
U.S. COVID-19: USA has now recorded a total of 205,114 deaths and more than 7,149,073 in the country have been infected. In the last 24 hours, 37,418 new cases were recorded and only 355 COVID-19 deaths were recorded.
Despite the low death rates and moderate infection rates in the last few days, the rate of positive COVID-19 tests is ticking up in New York, especially in neighborhoo...
Excess Deaths: A University of Leeds led study has shown that there were more than 2085 excess deaths in England and Wales due to heart disease and stroke during the peak of the COVID-19 pandemic stretching over 4 months (2nd March to 30th June 2020) with an average of 17 deaths per day. The researchers say that most of these deaths could have been prevented. (Excess deaths are the number of death...
Source: COVID-19 Vaccine Exclusive Sep 29, 2020 1 year ago
COVID-19 Vaccine Exclusive: Adeno-associated viral vectors to deliver gene therapies and vaccines are a growing platform that is being used by more and more pharmaceutical companies in drug and vaccine development. But unknown to many there are possible repercussions taking such AAV vectors based meds or vaccines.
Two gene therapies using adeno-associated virus (AAV) vectors to deliver ge...
Source: Supplements For Coronavirus Sep 29, 2020 1 year ago
Supplements For Coronavirus: Researchers University of Groningen - Netherlands, in a new vitro research have demonstrated that the phytochemicals resveratrol and pterostilbene, have long-lasting antiviral effects against SARS-CoV-2 coronavirus.
Both resveratrol and pterostilbene are natural plant compound found in grapes, small berries and certain nuts.
The study findings are published on ...
COVID-19 Latest: Adding to the confusions and contradictions, a new study by researchers from the University of Mersin and the Mersin City Education And Research Hospital in Turkey found as men's testosterone level at baseline decreases, the probability for them to be in the intensive care unit (ICU) significantly increases.
The study findings suggest that the COVID-19 disease might a...
Virus News: Swedish researchers from the Karolinska Institutet in a new study claim that a type of anti-bacterial T cells known as MAIT cells, are strongly activated in individuals with moderate to severe COVID-19 disease.
The new research findings contribute to increased understanding about how the complex human host immune system responds against COVID-19 infection.
Severe COVID-...
Source: Antibody-Dependent Enhancement (ADE) Sep 28, 2020 1 year ago
Antibody-Dependent Enhancement (ADE): Researchers from the University of Miami, Miami VA Healthcare System and Express Gene in a news study have identified the anti-N Immunoglobulin G (IgG) antibodies against SARS-CoV-2 as possibly being the cause of the Antibody-Dependent Enhancement (ADE) phenomenon in patients experiencing COVID-19 severity. Furthermore the same antibodies could also act ...
Source: COVID-19 Headlines Sep 28, 2020 1 year ago
COVID-19 Headlines: In late July this year, Dr Anthony Fauci, the head of National Institute of Allergy and Infectious Diseases (NIAID) since 1984 was busy touting to the media and numerous health agencies while it was becoming clear that antibodies in some cases were not working and also has a short lifespan coupled with the fact that antibody resistant strains of the SARS-CoV-2 was emerging, a n...
News-COVID-19: A new study by researchers from University of Arizona-Tucson led by Dr Rajesh Khanna, Professor from the department of pharmacology has made a breakthrough discovery that the SARS-CoV-2 is also able to bind to the neuropilin-1 receptors in humans,(NRP-I) in the process disrupting certain pain signals pathways, hence making the human host impervious to pain that might otherwise be cr...
Source: COVID-19 Research Briefs Sep 28, 2020 1 year ago
COVID-19 Research Briefs:
1. Anti-Androgens For COVID-19
A team of scientist led by Dr Andy Goren, MD from Applied Biology and Dr Flavio A. Cadegiani, MD, MSc, PhD from Corpometria Institute in Brazil while studying the genetics of the androgen receptor discovered a possible breakthrough treatment for COVID-19.Their study elucidates the possible role of androgens in controlling...
Source: COVID-19 Herd Immunity Sep 28, 2020 1 year ago
COVID-19 Herd Immunity: Off late here has been reports covered in certain unreliable mainstream media and also non-credible medical media talking about certain cities like Manaus in Brazil attaining herd-immunity or worse another claiming that Japan has also attained herd immunity, such coverage are misleading and can sometimes cause more problems and danger as locals in those locations might deve...
Source: COVID-19 Diagnostics Sep 28, 2020 1 year ago
COVID-19 Diagnostics: Researchers from Duke University Medical Center-North Carolina have identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease, advancing a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases.
The un...
Source: COVID-19-Povidone-Iodine Sep 27, 2020 1 year ago
COVID-19- Povidone-Iodine: A study led by researchers from the University of Connecticut School of Medicine-Farmington along with experts from The Institute for Antiviral Research at Utah State University, Veloce BioPharma-Florida, ProHealth-Farmington and Ocean Ophthalmology-Florida has demonstrated that an antiseptic nasal spray containing povidone-iodine may help curb transmission of the SARS-C...
Source: COVID-19 Headlines Sep 27, 2020 1 year ago
Coronavirus Headlines TM : COVID-19 Cases In Myanmar Surging, Country May Go Into Total Lockdown With Massive Restrictions.
As cases are fast rising in Myanmar, its biggest city, Yangon is rapidly building new quarantine centers as it scrambles to contain the commercial hub's first significant coronavirus outbreak, with overworked medical staff fearing thousands more cases to co...
COVID-19-Airborne: The U.S. CDC a few days ago retracted an update on its website on the issues of the COVID-19 airborne spread claiming a variety of technical and admin errors but which many are saying the retraction was based on directives from the White House as election approaches.
A 2018 photo shows The Gesundheit II machine in Dr Donald Milton's
Public Health Aerobiology, Virology, and...
COVID-19 Latest: Researchers from more than 200 medical and research institutions globally in a new study have found that that certain auto-antibodies known as neutralizing auto-Abs against type I IFNs are the reasons that certain individuals are suffering from severe conditions of the COVID-19 disease.
&nb...
COVID-19 Scams? Biomed Lublin a Polish pharmaceutical company claims to have successfully completed the production of a drug for COVID-19.
The company released a media statement on September 23 that its initial research “has confirmed its efficacy” and that it now plans to begin non-commercial clinical trials, and that if all goes well Poland could be the first country in...
.png)
.jpg)
